JEOUNG KANG: Open Payments
NPI 1306324850 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,336 in 364 payments from 50 companies in 2025. Trend: 2023 $5,000 · 2024 $6,173 · 2025 $8,336
Food & beverage: $7,761Education: $609
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 37 | $941 |
| Janssen Biotech, Inc. | 21 | $570 |
| Incyte Corporation | 26 | $458 |
| Eisai Inc. | 18 | $420 |
| Celgene Corporation | 27 | $371 |
| PFIZER INC. | 14 | $340 |
| ABBVIE INC. | 17 | $316 |
| Novartis Pharmaceuticals Corporation | 13 | $307 |
| SEAGEN INC. | 3 | $285 |
| Merck Sharp & Dohme LLC | 12 | $271 |
Products named: CALQUENCE, Lenvima, REBLOZYL, EPKINLY, IMFINZI, OPDIVO, Enhertu, JAKAFI.
Industry payments across CA — which companies pay providers there.
